PBYI (STOCKS)
PUMA BIOTECHNOLOGY INC
$8.900000
+0.190000 (+2.18%)
Prev close: $8.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Alan H. Auerbach
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $455.29M
- Employees
- 172
- P/E (TTM)
- 17.23
- P/B (TTM)
- 3.28
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$0.16 | $0.04 | +0.1192 | +292.16% |
|
Mar 2026 (Q1)
|
$-0.07 | $-0.13 | +0.0626 | +47.21% |
|
Dec 2025 (Q4)
|
$0.26 | $0.23 | +0.0285 | +12.31% |
|
Sep 2025 (Q3)
|
$0.17 | $0.05 | +0.1241 | +270.37% |
Financial Statements
| Revenues | $231.24M |
| Benefits Costs and Expenses | $200.08M |
| Cost Of Revenue | $58.20M |
| Costs And Expenses | $200.81M |
| Gross Profit | $173.05M |
| Nonoperating Income/Loss | $732.00K |
| Operating Expenses | $142.61M |
| Selling, General, and Administrative Expenses | $71.17M |
| Depreciation and Amortization | $10.48M |
| Other Operating Expenses | $66.20M |
| Operating Income/Loss | $30.44M |
| Income/Loss From Continuing Operations After Tax | $26.72M |
| Income/Loss From Continuing Operations Before Tax | $31.17M |
| Income Tax Expense/Benefit | $4.45M |
| Income Tax Expense/Benefit, Current | $1.21M |
| Net Income/Loss | $26.72M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $26.72M |
| Net Income/Loss Available To Common Stockholders, Basic | $26.72M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $0.54 |
| Diluted Earnings Per Share | $0.52 |
| Basic Average Shares | 101,362,560 |
| Diluted Average Shares | 154,690,342 |
| Assets | $192.74M |
| Current Assets | $145.07M |
| Cash | $86.80M |
| Inventory | $13.32M |
| Prepaid Expenses | $3.59M |
| Other Current Assets | $41.36M |
| Noncurrent Assets | $47.66M |
| Fixed Assets | $103.00K |
| Other Non-current Assets | $47.56M |
| Liabilities | $54.19M |
| Current Liabilities | $49.83M |
| Accounts Payable | $3.11M |
| Wages | $5.41M |
| Other Current Liabilities | $41.31M |
| Noncurrent Liabilities | $4.37M |
| Equity | $138.54M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $138.54M |
| Liabilities And Equity | $192.74M |
| Net Cash Flow From Operating Activities | $41.15M |
| Net Cash Flow From Operating Activities, Continuing | $41.15M |
| Net Cash Flow From Investing Activities | -$16.03M |
| Net Cash Flow From Investing Activities, Continuing | -$16.03M |
| Net Cash Flow From Financing Activities | -$45.34M |
| Net Cash Flow From Financing Activities, Continuing | -$45.34M |
| Net Cash Flow | -$20.22M |
| Net Cash Flow, Continuing | -$20.22M |
| Comprehensive Income/Loss | $26.69M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $26.69M |
| Other Comprehensive Income/Loss | $26.69M |